Clinical Research Directory
Browse clinical research sites, groups, and studies.
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
Sponsor: Vivek Jain
Summary
This study will investigate if an intra-nasal nose spray of the drug oxytocin can decrease the amount of pressure needed from the automatic Continuous Positive Airway Pressure (CPAP) device while sleeping decreasing some of the harmful effects of low oxygen in people with sleep apnea. This study will last 35 nights and involves spending three nights in the sleep lab at George Washington University. There are no additional costs to participants and no compensation for being involved in the study.
Official title: Benefits of Oxytocin in OSA Patients Using CPAP
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2019-03-04
Completion Date
2026-03-01
Last Updated
2025-03-21
Healthy Volunteers
No
Conditions
Interventions
Oxytocin
40 IU administered intranasal, within 1 hour prior to sleeping for 14 days
Placebo
Intranasal spray to mimic Oxytocin intranasal spray
Locations (1)
Medical Faculty Associates
Washington D.C., District of Columbia, United States